External Source

#esmo22 Highlights On Abemaciclib + Nsai In Hr+/her2- Advanced Breast Cancer: The Monarch 3 Study

2022 2:37
Synopsis
LBA15 - MONARCH 3: Interim overall survival (OS) results of abemaciclib plus a nonsteroidal aromatase inhibitor (NSAI) in ...

You Might Also Like

Abemaciclib plus NSAI for HR+, HER2- advanced breast cancer - MONARCH 3 interim data 4:19
Abemaciclib Plus Nsai For Hr+, Her2- Advanced Breast Cancer ...
2022
Comment: MONARCH 3 trial: Abemaciclib for advanced breast cancer 1:46
Comment: Monarch 3 Trial: Abemaciclib For Advanced Breast Ca...
2017
MONARCH 3: Abemaciclib as initial therapy for patients with HR /HER2- advanced breast cancer 4:45
Monarch 3: Abemaciclib As Initial Therapy For Patients With ...
2017
Sara Tolaney, ESMO 2022: Clinical trial highlights in breast cancer 2:46
Sara Tolaney, Esmo 2022: Clinical Trial Highlights In Breast...
2022
Metastatic breast cancer at ESMO 2022: TROPiCS02, MONARCH 3 and SYNERGY 5:37
Metastatic Breast Cancer At Esmo 2022: Tropics02, Monarch 3 ...
2022
MONARCH 2: abemaciclib added to fulvestrant shows OS benefit in HR+/HER2- advanced breast cancer 5:12
Monarch 2: Abemaciclib Added To Fulvestrant Shows Os Benefit...
2019
Breast cancer trials of interest at ESMO 2022 2:51
Breast Cancer Trials Of Interest At Esmo 2022
2022
Significance of the MONARCH 2 Findings for Abemaciclib in HR+/HER2- Breast Cancer 1:13
Significance Of The Monarch 2 Findings For Abemaciclib In Hr...
2017
Next Steps Beyond the MONARCH 1 Trial in Breast Cancer 0:50
Next Steps Beyond The Monarch 1 Trial In Breast Cancer
2016
Abemaciclib for HR+/HER2- advanced or metastatic breast cancer 1:39
Abemaciclib For Hr+/her2- Advanced Or Metastatic Breast Canc...
2021
ESMO22: Breast cancer research by Sara Tolaney, MD (TROPiCS) | Dana-Farber Cancer Institute 1:18
Esmo22: Breast Cancer Research By Sara Tolaney, Md (tropics)...
2022
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.